ABIVAX Société Anonyme Cash Flow Statement Analysis

Operating, investing, and financing activities in millions EUR

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for ABIVAX Société Anonyme (ABVX) - Annual data in millions EUR
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Operating Activities
Net Income-176.24-147.74-60.74-42.45-37.55
Depreciation & Amortization1.100.710.490.300.07
Stock Based Compensation20.228.18-1.160.830.00
Change in Working Capital1.4221.27-2.00-0.679.67
Change in Accounts Receivable4.59-14.230.31-1.982.66
Change in Accounts Payable-3.4431.76-2.291.140.00
Change in Other Working Capital-2.0521.546.64-0.757.01
Other Operating Activities-0.5620.496.64-3.06-2.00
Net Cash from Operating Activities-154.07-97.13-53.94-45.05-29.82
Investing Activities
Capital Expenditures-0.64-0.27-0.32-0.05-0.90
Acquisitions0.000.00-2.91-2.180.00
Purchases of Investments0.00-9.35-0.47-0.010.00
Sales/Maturities of Investments0.000.740.220.000.00
Other Investing Activities16.41-7.83-8.79-4.01-0.29
Net Cash from Investing Activities15.76-8.10-12.03-6.23-0.58
Financing Activities
Debt Repayment-10.46-40.60-9.71-5.790.00
Common Stock Issued0.43353.3946.3769.6826.40
Other Financing Activities-7.01-33.23-0.44-6.060.00
Net Cash from Financing Activities28.21335.2932.2182.6849.93
Summary
Effect of Forex Changes on Cash2.38-5.070.000.000.00
Net Change in Cash-107.72224.99-33.7531.4019.53
Cash at Beginning of Period251.9426.9560.7029.300.00
Cash at End of Period144.22251.9426.9560.700.00
Free Cash Flow-154.71-97.40-54.26-45.10-30.72
Supplemental Disclosures
Interest Paid7.705.284.021.911.55